ALI
532 drugs in development·198 companies·1 clinical trial
Drug Pipeline by Phase
Approved(115)
Phase 3(121)
Phase 2(71)
Phase 1(95)
Preclinical(34)
Unknown(33)
BLA Filed(1)
| Drug | Company |
|---|---|
| imsidolimab | ANAPTYSBIO, INC (ANAB) |
Early Phase 1(2)
N/A(5)
Phase 1/Phase 2(39)
Phase 2/Phase 3(4)
Phase 4(12)
Compare drugs
Frequently asked questions
How many drugs are in development for ALI?
BioSniper tracks 532 drugs in development for ALI across 198 companies.
How many clinical trials target ALI?
There are 1 clinical trial targeting ALI tracked by BioSniper.
Deep-dive into ALI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis